Strive Inc: Matthew Cole Increases Stake with $455K Purchase
ASST has more than doubled off its 52-week low of $0.387.
Summary
Matthew Cole, a reporting person in this 13D/A filing, acquired 500,000 shares of Strive, Inc. at prices ranging from $0.91 to $0.92, totaling approximately $455,000. This purchase increases his stake and reflects updated ownership percentages following the Semler Scientific acquisition and additional share issuances.
Key Events · Ownership and Investor Activity · ASST
-
Matthew Cole Acquires Additional Shares
Matthew Cole purchased 500,000 shares of Class A Common Stock at prices between $0.91 and $0.92 on January 13, 2026, totaling approximately $455,000.
-
Updated Ownership Percentages
The filing reflects updated ownership percentages due to the issuance of shares related to the Semler Scientific acquisition and vested compensation shares.
Analysis · ASST · Crypto Assets
Matthew Cole's purchase of 500,000 shares at prices between $0.91 and $0.92 indicates a bullish sentiment. This activity, disclosed in an amended 13D, adds to the ownership changes resulting from the Semler Scientific acquisition and vested compensation shares. Investors should monitor further insider activity for confirmation of this positive signal.
At the time of this filing, ASST was trading at $0.89 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $780.5M. The 52-week trading range was $0.39 to $13.42. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.